Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc.

NASDAQ:ETON

Overview | Financials
Company Name Eton Pharmaceuticals, Inc.
Symbol ETON
Currency USD
Price 3.62
Market Cap 92,999,972
Dividend Yield 0%
52-week-range 2.42 - 5.81
Industry Biotechnology
Sector Healthcare
CEO Mr. Sean E. Brynjelsen
Website https://www.etonpharma.com

An error occurred while fetching data.

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia

Related Stocks

BioAtla, Inc. logo

BioAtla, Inc.

BCAB

2.83 USD

Akumin Inc. logo

Akumin Inc.

AKU

0.289 USD

Vigil Neuroscience, Inc. logo

Vigil Neuroscience, Inc.

VIGL

3.52 USD

Wave Life Sciences Ltd. logo

Wave Life Sciences Ltd.

WVE

6.26 USD

SAB Biotherapeutics, Inc. logo

SAB Biotherapeutics, Inc.

SABS

3.63 USD

Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc.

ASMB

14.53 USD

Lipocine Inc. logo

Lipocine Inc.

LPCN

6.04 USD

Financials

Numbers are in millions USD

Numbers are in millions USD